Get started
Chimerix, Inc.Chimerix, Inc.Chimerix, Inc.

Chimerix, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

CMRX trade ideas

CMRX 2/7/2020Analysis- Daily chart- After long downtrend, price has been in sideways market between 1.24-3.38 for 638 days. After making a move to resistance on July2020, price fell and found support from 200 MA then working itself back to resistance and finally breaking out. After breakout of 40%, price pulled back but was supported by 10MA were it went on to make another move of 111%. The bounce of the 10ma signals very strong bull strength. Since that move, Price has found resistance @ 9.33 area but has made a series of higher lows and is still supported by 10ma. This is all signaling very strong buy strength by bulls. Will look into 1hr chart for possible entry. 1hr Chart- Price is current above both 50 & 200 MAs, showing us the uptrend on the 1hr chart. The price bounce off Resistance area of 9.33-9.51 with the exceptions of a few false breakouts. It has now made a series of higher lows into this level showing us buyers willingness to buy at higher prices. On 2/5/2020, price broke above resistance and bounced off turning resistance into support. This is my entry signal. Entry: 9.73 Stop Loss: 8.85(-9.14%) Initial Target: Trailing 10MA on daily chart
NASDAQ:CMRXLong
by rudcharts
CMRX daily 160% gains setup(STOCKS)before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -15+ years real live trading experience -TOP Author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it short/simple and to the point. CMRX daily 160% gains setup(STOCKS) Strong accumulation in progress. Wait for dip/pullback and MKT BUY from GAP FILL area (1.75USD). TP1 bulls +125% gains TP2 bulls +160% gains. this is BUY/HOLD setup, DO NOT expect miracle/overnight gains, this is not leveraged trading on Bitmex... good luck traders! get subbed to stay tuned for all the latest updates. also add likes to support my efforts, thank you.
NASDAQ:CMRXLong
by ProjectSyndicate
5
$CMRX Chimerix Inc Moving big pore market - Covid-19DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patients with acute lung injury (ALI). DSTAT is a glycosaminoglycan derivative of heparin with robust anti-inflammatory properties, including the potential to address underlying causes of coagulation disorders with substantially reduced risk of bleeding complications compared to commercially available forms of heparin.1 “Given the severity of the COVID-19 pandemic, we have evaluated many potential targets to address the clinical manifestations associated with severe COVID-19,”said Joseph Lasky, M.D., Professor of Medicine, Pulmonary and Critical Care Section Chief, John W. Deming, M.D. Endowed Chair in Internal Medicine at Tulane University Medical School. “Based on the literature, we believe DSTAT has the potential to reduce the excessive inflammation, immune cell infiltration and hypercoagulation associated with poor outcomes in patients with severe COVID-19 infection.” “DSTAT is well-suited to unlock the anti-inflammatory properties of heparin as it may be dosed at much higher levels than any available form of heparin without triggering bleeding complications,” said Mike Sherman, Chief Executive Officer of Chimerix. “We had planned to evaluate DSTAT in several indications of high unmet need, including ALI from different causes. The pandemic intensified our focus on ALI associated with COVID-19. Our team has worked closely with critical care physicians treating COVID-19 patients and with the U.S. Food and Drug Administration (FDA) to develop a Phase 2/3 protocol to determine if DSTAT can reduce the need for mechanical ventilation and improve the rate of survival in patients with severe COVID-19 infection.”
NASDAQ:CMRXLong
by DEXWireNews
CHIMERIX INC. - NASDAQ: $CMRX Shaping-UpAfter breaking higher in early April on large volume, Chimerix Inc. (NASDAQ:CMRX) spent the next several weeks digesting/consolidating the move before breaking higher yet again last month (May) and in the process, recapturing its 200 DMA as evidenced in the Daily chart above. With the stock presently trading above all of its important moving averages (20/50/200 DMA's), CMRX remains in a favorable technical posture. Moving forward, should CMRX be capable of clearing the $3.80 hurdle, such development would likely trigger its next advance into higher ground. Nevertheless, CMRX remains in decent shape from a technical lens and both investors/traders may want to continue to monitor the action closely in the days/weeks ahead.
NASDAQ:CMRX
by InsiderFinancial
CMRX - MORNING PANIC @ 2.45Will be looking this to have a morning panic biggest gainers today however closed very high and very near high of day. The main thing that stands out to me is the afternoon breakout I say this has pushed to over extension I will be looking for the panic to play, no panic no play entry point near 2.45 short float not very high though 2.32% may be enough to set if off. Pattern is based of the overextend closing. 1 year chart not flattering thou the ytd is uptrending
NASDAQ:CMRXShort
by kiwiktrader
Chimerix Inc (NASDAQ:CMRX) An Ebola BuyIn the last few weeks there has been quite a lot of movement in shares of Chimerix Inc (NASDAQ:CMRX). This company reportedly had a drug that would help fight the nasty Ebola virus. Once the market caught wind of this, Chimerix Inc (NASDAQ:CMRX) shot up nearly 50% in a few trading sessions. Since making a high of $36.75 the share price has dropped about 20% as the Ebola fears subsided and traders/investors took profits. So where is the stock of Chimerix Inc (NASDAQ:CMRX) headed? I have isolated two very good support levels at $25.75 and $22.75. These price targets should provide a substantial amount of support as these were the breakout levels and there are also some proprietary calculations which point to these numbers. My advice to those who wish to buy this company is to initiate a position at the first price level and then add at the lower level if it continues to sell off. This is a very volatile stock, so keep your position small and look be rewarded in a big way. If you are looking for market guidance and direction, make sure it comes from the Elite Round Table. We have been giving members double digit returns in days in these volatile markets. Our FREE market emails contain information that can actually make you money for both short term trading and long term investing. Parm Mann Elite Round Table Follow me on twitter: @ParmMannTrader
NASDAQ:CMRX
by Parm